Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors - Concepedia

Concepedia

Publication | Open Access

Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors

DOI Full Paper Access

109

Citations

51

References

2022

Year

Amin H. Nassar, Elio Adib, Sarah Abou Alaiwi, Talal El Zarif, Stefan Groha, Elie W. Akl, Pier Vitale Nuzzo, Tarek H. Mouhieddine, Tomin Perea-Chamblee, Kodi Taraszka,

Tumor Mutational BurdenCancer ImmunosurveillanceTumor HeterogeneityMedicineImmunologyAncestry-driven RecalibrationPathologyCancer GenomicsImmune Checkpoint InhibitorClinical OutcomesCancer GeneticsImmunotherapyOncologyCancer ResearchHealth Sciences

References

	Year	Citations

Page 1

Page 1